Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice

International Immunopharmacology

Volumn 7, Issue 3, 2007, Pages 392-400

  Zhou, Lili ^a   Ni, Bing ^b   Luo, Deyan ^a   Zhao, Guangyu ^a   Jia, Zhengcai ^b   Zhang, Liangyan ^a   Lin, Zhihua ^c   Wang, Li ^b   Zhang, Songle ^a   Xing, Li ^a   Li, Jintao ^b   Liang, Yunfei ^b   Shi, Xinfu ^a   Zhao, TingTing ^b   Zhou, Liyun ^b   Wu, Yuzhang ^b   Wang, Xiliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Aged; Equine; F(ab')2; Infection; Mice; SARS CoV

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; NEUTRALIZING ANTIBODY;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; INFECTION PREVENTION; LUNG; METHODOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; VALIDITY; VIRUS LOAD;

AGING; ANIMALS; ANTIBODIES, VIRAL; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HORSES; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; MICE, INBRED BALB C; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33846579685     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.10.009     Document Type: Article

References (34)

1. Enserink M., and Normile D. Infectious diseases. Search for SARS origins stalls. Science 302 5646 (2003) 766-767
2. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302 5643 (2003) 276-278
3. Saif L.J. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome?. Rev Sci Tech 23 2 (2004) 643-660
4. Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289 21 (2003) 2801-2809
5. Chan J.W., Ng C.K., Chan Y.H., Mok T.Y., Lee S., Chu S.Y.Y., et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 58 8 (2003) 686-689
6. Donnelly C.A., Ghani A.C., Leung G.M., Hedlev A.J., Fraser C., Riley S., et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361 9371 (2003) 1761-1766
7. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348 20 (2003) 1986-1994
8. Peiris J.S., Chu C.M., Cheng V.C., Chan K.S., Hung I.F., Poon L.L., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 9371 (2003) 1767-1772
9. Tsui P.T., Kwok M.L., Yuen H., and Lai S.T. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 9 9 (2003) 1064-1069
10. Roberts A., Paddock C., Vogel L., Butler E., Zaki S., and Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 79 9 (2005) 5833-5838
11. Keller M.A., and Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 13 4 (2000) 602-614
12. Soo Y.O., Cheng Y., Wong R., Hui D.S., Lee C.K., Tsang K.K., et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 10 7 (2004) 676-678
13. Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 78 7 (2004) 3572-3577
14. Lang J., Attanath P., Quiambao B., Singhasivanon V., Chanthavanich P., Montalban C., et al. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop 70 3 (1998) 317-333
15. Chiba T., Yokosuka O., Goto S., Fukai K., Imazeki F., Shishido H., et al. Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine. Eur J Haematol 71 3 (2003) 220-223
16. Dahmen U., Dirsch O., Li J., Fiedle M., Lu M., Rispeter K., et al. Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation. Transplantation 77 7 (2004) 965-972
17. Watt G., Kantipong P., Jongsakul K., de Souza M., and Burnouf T. Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study. QJM 94 11 (2001) 599-607
18. Ruprecht R.M., Ferrantelli F., Kitabwalla M., Xu W., and McClure H.M. Antibody protection: passive immunization of neonates against oral AIDS virus challenge. Vaccine 21 24 (2003) 3370-3373
19. Wang X., Ni B., Du X., Zhao G., Gao W., Shi X., et al. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody. Antivir Ther 10 5 (2005) 681-690
20. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 4 (2001) 386-401
21. Bhaskar G., Lodha R., and Kabra S.K. Severe acute respiratory syndrome (SARS). Indian J Pediatr 70 5 (2003) 401-405
22. Grinblat L., Shulman H., Glickman A., Matukas L., and Paul N. Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology 228 3 (2003) 802-809
23. Muller N.L., Ooi G.C., Khong P.L., and Nicolaou S. Severe acute respiratory syndrome: radiographic and CT findings. AJR Am J Roentgenol 181 1 (2003) 3-8
24. Ooi G.C., and Daqing M. SARS: radiological features. Respirology 8 (2003) S15-S19 [Suppl]
25. Paul N.S., Roberts H., Butany J., Chung T., Gold W., Mehta S., et al. Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience. Radiographics 24 2 (2004) 553-563
26. Raoof S., Raoof S., and Naidich D.P. Imaging of unusual diffuse lung diseases. Curr Opin Pulm Med 10 5 (2004) 383-389
27. Peiris J.S., Guan Y., and Yuen K.Y. Severe acute respiratory syndrome. Nat Med 10 12 Suppl (2004) S88-S97
28. Wang W.K., Chen S.Y., Liu I.J., Kao C.L., Chen H.L., Chiang B.L., et al. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis 39 7 (2004) 1071-1075
29. Ho M.S., Chen W.J., Chen H.Y., Lin S.F., Wang M.C., Di J., et al. Neutralizing antibody response and SARS severity. Emerg Infect Dis 11 11 (2005) 1730-1737
30. Sui J., Li W., Murakami A., Matthews L.J., Wong S.K., Moore M.J., et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 101 8 (2004) 2536-2541
31. Sui J., Li W., Roberts A., Matthews L.J., Murakami A., Vogel L., et al. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol 79 10 (2005) 5900-5906
32. ter Meulen J., Bakker A.B., van den Brink E.N., Weverling G.J., Martina B.E., Haagmans B.L., et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363 9427 (2004) 2139-2141
33. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10 8 (2004) 871-875
34. Duan J., Yan X., Guo X., Cao W., Han W., Qi C., et al. A human SARS-CoV neutralizing antibody against epitope on S2 protein. Biochem Biophys Res Commun 333 1 (2005) 186-193